Gilead Sciences Inc(GILD)

68.29

Change: 0 (0)

As of Mon 08/02/2021 03:01 AM

% Of Value

Growth

Value Per Share

:

:

:

147.78

9.98

46.2100 (as of 19/07/2019)

NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY

Fundamentals Data

Open 67.80 Dividend 1358
Close Price 68.29 DivYield 2.42 %
High 67.83 Growth 2.2 B
Low 66.66 Growth% 9.98
P/e 15.28 Volume 5.7 M
P/b 11.39 Market Capital 78.9 B
Highest High 85.47 Lowest Low 64.12
50 Days Moving Average 65.95 (as of 03/07/2019) 50 Days Moving Average Percentage -5.904 (as of 03/07/2019
Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Charts for balance Sheet:

Balance Sheet Table: last 5 years

Note: Numbers are estimated, Exact figures can be found in Annual Reports
Type Year1 / 2016 Year2 / 2017 Year3 / 2018 Year4 / 2019 Current Year / 2020
Revenue 30.3 B 26.1 B 22.1 B 22.4 B 24.6 B
Cap Spending -748.0 M -590.0 M -924.0 M -825.0 M -650.0 M
Operating Expenses 8.4 B 7.6 B 9.0 B 13.4 B 16.0 B
Operating Cash Flow 17.6 B 14.1 B 8.2 B 4.2 B 4.0 B
Free Cash Flow 15.9 B 11.3 B 7.4 B 8.3 B 7.5 B
Free Cash Flow Per Share 11.89 8.652 5.76 6.55 5.981
Total liabilities 26.3 B 33.5 B 27.3 B 24.5 B 31.4 B
Total cash 8.2 B 7.5 B 17.9 B 11.6 B 5.9 B
ROE% 0.835 0.209 0.252 0.246 0.006
Outstanding Shares 1.3 B 1.3 B 1.2 B 1.2 B 1.2 B
P/E 6.825 22.746 15.264 16.447 641.475
P/S 3.032 4.032 3.763 3.946 3.196
Revenue USD 30.3 B 26.1 B 22.1 B 22.4 B 24.6 B

Reports for GILD

Date Author Title Action
2020-09-08 stanko Gilead Sciences equity, debt and subsidiaries view
2016-10-13 stanko gilead is the leader of hep C drugs and 14 brand names with 1/3 of market cap in debt view

Latest Searches

Stock Close Price %of value Date